首页 >
法规速递
-
Page: Interoperability assessment at EMA-2025/10/10
2025-10-11查看详情 > -
关于公开征求《药物研发及申报临床常见问题技术指导原则（征求意见稿）》意见的通知-2025/11/18
2025-11-19查看详情 > -
Document: Work plan for the Committee for Veterinary Medicinal Products (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2026-2025/12/12
2025-12-15查看详情 > -
Document: Agenda of the CHMP meeting 26-29 January 2026-2026/1/26
2026-01-27查看详情 > -
Document: Darwin EU study: Treatment patterns and user characteristics for novel migraine medicines-2026/3/4
2026-03-05查看详情 > -
Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)-2026/4/1
2026-04-02查看详情 > -
国家药监局关于发布药品试验数据保护实施办法的公告（2026年第47号） -2026/5/15
2026-05-17查看详情 > -
Scientific guideline: Draft reflection paper on the application of Article 40(5) of Regulation (EU) 2019/6 for certain categories of variations-2022/11/24
2022-11-30查看详情 > -
Guidance for Industry - Migraine: Developing Drugs for Preventive Treatment Drug Trials Snapshot: PYRUKYND-2023/6/1
2023-06-02查看详情 > -
国家药监局综合司关于“可降解膨胀止血绵”类产品分类界定的通知-2023/12/6
2023-12-21查看详情 >
